InnovAge Holding Corp. Increase (Decrease) in Accounts Payable and Accrued Liabilities
InnovAge Holding Corp. (INNV) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $38.45 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-09-09
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $9.98M, a 2605.15% increase year-over-year.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $48.05M, a 177.05% increase year-over-year.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $4.71M, a 61.41% decline year-over-year.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$24.30M.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was $38.45M, a 88.17% increase from fiscal 2025.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $20.43M, a 1391.31% increase from fiscal 2024.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $1.37M, a 79.81% decline from fiscal 2023.
- InnovAge Holding Corp. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $6.79M, a 60.96% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $58.04M derived: sum of 2 quarters · filed 2026-09-09 | $62.75M derived: sum of 3 quarters · filed 2026-09-09 | $38.45M 10-K · filed 2026-09-09 | |
| 2026-03-31 | $48.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $52.77M derived: sum of 2 quarters · filed 2026-05-08 | $28.46M 10-Q · filed 2026-05-08 | $28.83M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-12-31 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$19.59M 10-Q · filed 2026-02-03 | -$19.22M derived: sum of 3 quarters · filed 2026-09-09 | -$1.88M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-09-30 | -$24.30M 10-Q · filed 2025-11-04 | -$23.93M derived: sum of 2 quarters · filed 2026-09-09 | -$6.59M derived: sum of 3 quarters · filed 2026-09-09 | $5.62M derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-06-30 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $17.71M derived: sum of 2 quarters · filed 2026-09-09 | $29.93M derived: sum of 3 quarters · filed 2026-09-09 | $20.43M 10-K · filed 2026-09-09 | |
| 2025-03-31 | $17.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $29.56M derived: sum of 2 quarters · filed 2026-05-08 | $20.06M 10-Q · filed 2026-05-08 | $26.83M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $12.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $2.72M 10-Q · filed 2026-02-03 | $9.49M derived: sum of 3 quarters · filed 2026-02-03 | $6.33M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-09-30 | -$9.49M 10-Q · filed 2025-11-04 | -$2.72M derived: sum of 2 quarters · filed 2025-11-04 | -$5.88M derived: sum of 3 quarters · filed 2025-11-04 | -$822.00K derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $3.62M derived: sum of 2 quarters · filed 2025-09-09 | $8.67M derived: sum of 3 quarters · filed 2025-09-09 | $1.37M 10-K · filed 2025-09-09 | |
| 2024-03-31 | -$3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $1.90M derived: sum of 2 quarters · filed 2025-05-06 | -$5.40M 10-Q · filed 2025-05-06 | -$23.78M derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | $5.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | -$2.25M 10-Q · filed 2025-02-04 | -$20.62M derived: sum of 3 quarters · filed 2025-02-04 | $5.08M derived: sum of 4 quarters · filed 2025-02-04 | |
| 2023-09-30 | -$7.30M 10-Q · filed 2024-11-05 | -$25.68M derived: sum of 2 quarters · filed 2024-11-05 | $27.00K derived: sum of 3 quarters · filed 2024-11-05 | -$1.67M derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | -$18.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $7.33M derived: sum of 2 quarters · filed 2024-09-10 | $5.63M derived: sum of 3 quarters · filed 2024-09-10 | $6.79M 10-K · filed 2024-09-10 | $34.90M 10-K · filed 2023-09-12 |
| 2023-03-31 | $25.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $24.01M derived: sum of 2 quarters · filed 2024-05-07 | $25.16M 10-Q · filed 2024-05-07 | $37.84M derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | -$544.00K 10-Q · filed 2024-02-06 | $12.13M derived: sum of 3 quarters · filed 2024-02-06 | $9.24M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-09-30 | $1.16M 10-Q · filed 2023-11-07 | $13.83M derived: sum of 2 quarters · filed 2023-11-07 | $10.94M derived: sum of 3 quarters · filed 2023-11-07 | $17.29M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $12.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | $9.79M derived: sum of 2 quarters · filed 2023-09-12 | $16.13M derived: sum of 3 quarters · filed 2023-09-12 | $17.38M 10-K · filed 2023-09-12 | |
| 2022-03-31 | -$2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-09 | $3.46M derived: sum of 2 quarters · filed 2023-05-09 | $4.71M 10-Q · filed 2023-05-09 | $3.13M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $6.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $7.60M 10-Q · filed 2023-02-07 | $6.02M derived: sum of 3 quarters · filed 2023-02-07 | $11.38M derived: sum of 4 quarters · filed 2023-02-07 | |
| 2021-09-30 | $1.25M 10-Q · filed 2022-11-08 | -$332.00K derived: sum of 2 quarters · filed 2022-11-08 | $5.03M derived: sum of 3 quarters · filed 2022-11-08 | $1.59M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $3.79M derived: sum of 2 quarters · filed 2022-09-13 | $339.00K derived: sum of 3 quarters · filed 2022-09-13 | $6.14M 10-K · filed 2022-09-13 | |
| 2021-03-31 | $5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-10 | $1.92M derived: sum of 2 quarters · filed 2022-05-10 | $7.72M 10-Q · filed 2022-05-10 | $5.33M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09 | $2.35M 10-Q · filed 2022-02-09 | -$34.00K derived: sum of 3 quarters · filed 2022-02-09 | ||
| 2020-09-30 | $5.80M 10-Q · filed 2021-11-09 | $3.41M derived: sum of 2 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | -$1.01M 10-K · filed 2021-09-23 | |||
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |